Pengli Li
About Pengli
Pengli Li focuses her practice on the representation of public companies and investment banks on capital markets transactions, including initial and follow-on equity and debt offerings. She also advises public companies on SEC compliance and reporting, as well as corporate governance matters.
Experience
-
Tourmaline Bio Enters Into Agreement to be Acquired by Novartis
-
Tempus Announces Upsized $650 Million Convertible Senior Notes Offering
-
PhaseBio Chapter 11 Wind-Down Plan Goes Effective
-
Core Scientific to Combine With SPAC Power & Digital Infrastructure Acquisition Corp.
-
Finch Therapeutics – $128 Million IPO
Admissions and credentials
- Massachusetts
- New York
Get In Touch
Location
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.